Why could patients with heart failure and T2DM benefit from SGLT2 inhibition?
25 May 2019 (13:40 - 13:55)
Organised by:
About the speaker
St. Michael's Hospital, Toronto (Canada)
4 More presentations in this session
Professor C. Lam (Singapore, SG)
Professor A. Voors (Groningen, NL)
Professor M. Cowie (London, GB)
Access the full session
The Event
Heart Failure 2019
25 May 2019
13:40 CET
You may be interested in
Congress Presentation
Congress Session
Webinar
Congress Presentation
